Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease
about
Cellular Reprogramming Using Defined Factors and MicroRNAsModeling Alzheimer's Disease with Induced Pluripotent Stem Cells: Current Challenges and Future ConcernshiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineGeneration of diverse neural cell types through direct conversionInduced pluripotent stem cells for modeling neurological disordersUsing iPS Cells toward the Understanding of Parkinson's DiseaseModelling human disease with pluripotent stem cellsNeural differentiation from pluripotent stem cells: The role of natural and synthetic extracellular matrixDrug repositioning approaches for the discovery of new therapeutics for Alzheimer's diseaseNeurodegenerative diseases in a dish: the promise of iPSC technology in disease modeling and therapeutic discoveryAn over expression APP model for anti-Alzheimer disease drug screening created by zinc finger nuclease technologyHuman pluripotent stem cells on artificial microenvironments: a high content perspectiveStem cells in dermatologyEnhanced derivation of human pluripotent stem cell-derived cortical glutamatergic neurons by a small molecule.Stem cell models of Alzheimer's disease: progress and challenges.Concise review: modeling central nervous system diseases using induced pluripotent stem cellsProbing the secrets of Alzheimer's disease using human-induced pluripotent stem cell technology.Small molecule screening in human induced pluripotent stem cell-derived terminal cell types.Promoting effect of 1,25(OH)2 vitamin D3 in osteogenic differentiation from induced pluripotent stem cells to osteocyte-like cells.N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neuronsGenomics in neurological disorders.Connectivity and circuitry in a dish versus in a brainOpportunities and Limitations of Modelling Alzheimer's Disease with Induced Pluripotent Stem CellsAlzheimer's disease in a dish: promises and challenges of human stem cell models.Microglia-targeted stem cell therapies for Alzheimer disease: A preclinical data review.Brain Aggregates: An Effective In Vitro Cell Culture System Modeling Neurodegenerative Diseases.Panax notoginsenoside Rb1 ameliorates Alzheimer's disease by upregulating brain-derived neurotrophic factor and downregulating Tau protein expressionConcise review: drug discovery in the age of the induced pluripotent stem cell.Deciphering the molecular profile of plaques, memory decline and neuron loss in two mouse models for Alzheimer's disease by deep sequencing.Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer's disease.Current status of drug screening and disease modelling in human pluripotent stem cells.Embryonic and induced pluripotent stem cell differentiation as a tool in neurobiology.Role of mass spectrometry-based proteomics in the study of cellular reprogramming and induced pluripotent stem cells.Cellular reprogramming: a new approach to modelling Parkinson's disease.In-a-dish: induced pluripotent stem cells as a novel model for human diseases.Induced pluripotency for translational researchThe winding road to pluripotency (Nobel Lecture).Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.Stem cells for investigation and treatment of inherited retinal disease.Induced pluripotent stem cells for regenerative medicine
P2860
Q26744303-09FB02BC-DD22-4242-AD82-8791648E17CAQ26745513-93B19038-7B07-433D-8829-9C97C95D5DD9Q26751506-11D1D101-B8C6-4BF6-A0E1-4B216368DB27Q26765258-59F11D10-E04F-412E-AB25-9068551E744DQ26771402-39F07644-2DEC-44AA-AD80-E0401E16F5A5Q26799590-0C2A116A-1095-4F22-B066-3AED51A2FC31Q26864380-8CB1A142-3C49-441D-8A2A-1EB72D8E43D5Q27007542-32322F57-5DFA-4326-94B4-4751C61D4EFEQ27024122-FB322370-142A-4221-9CF9-F1D4CD7B55F0Q27025493-A29D1853-8CD9-4D63-A301-32E240AC8547Q28534870-A1C79629-2178-4EF5-B4D3-E4A5A4AE6508Q28656439-36EE0896-9819-47FB-8F2D-C41543AFFD4EQ33558576-CF70E591-235A-421F-B84A-A12C31FBC8DAQ33789516-120916F9-3754-44B7-85CE-F25D9A17F3C1Q33796378-E82B02E7-B9A4-4660-8F99-726ACFB6E39BQ34601914-03611895-0E68-4405-B8A0-047D31293E67Q35064977-CF15C4BE-9996-417E-BC83-1C59653CA244Q35074117-145A9ECE-B3F5-4443-BD17-6A4F394C148FQ35133864-75259FC8-F9AC-43E4-A3BC-727D8BCFA901Q35144310-3FC9C2C7-2CD3-4C71-A4F6-5AAD265047BDQ35543494-8B242F3A-08FB-431D-B064-5944825001AFQ35684598-8B0B4156-BFE7-4834-84E6-4DC2D59DCDDEQ35750557-3783D563-49EA-44D9-94AC-3DB18DAA6C07Q36283888-6BFFC18D-4D0A-4E07-AFA8-FC3A221C4D5DQ36413131-2BDE772D-820C-4B93-801C-6269138DF317Q36994348-9C849E25-1D53-466F-A5A2-18E927F720E3Q37207059-4C5125C8-0103-4B33-B5F6-E0202F03A718Q37680999-E6E6180F-11B8-4869-B9ED-665F61752A5AQ37718997-B21801C5-0E0F-4705-9D5D-90C3560774BFQ38018504-090CFB1B-FA22-4ACE-B032-E2AC7A94EBA7Q38034129-939F06A9-D024-48B9-943A-CD78FC301C47Q38034476-DB279724-488C-4993-A5B0-3333EBD9AF84Q38042456-F0D6B5FD-7887-468A-ACC2-C3C2F943772FQ38044447-5A73AE1A-9729-44F3-AF7F-FF0B38470C31Q38071032-8130BFE2-3DB3-49B1-B98B-FAA3E7D14939Q38140541-FF5D5ACA-2DA0-4F98-86A0-1B29A3CAFE58Q38164317-3C2BCCE6-634C-457B-B7C1-D08E062C21B4Q38185612-6D80AD04-EA18-4CC4-8E2F-6B54949B183EQ38197508-7392846E-5823-4048-92DD-3093EFE3897BQ38218254-F01EF465-9F75-44CE-85BA-2FC987C3F717
P2860
Anti-Aβ drug screening platform using human iPS cell-derived neurons for the treatment of Alzheimer's disease
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@ast
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@en
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@nl
type
label
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@ast
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@en
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@nl
prefLabel
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@ast
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@en
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@nl
P2093
P2860
P3181
P1433
P1476
Anti-Aβ drug screening platfor ...... eatment of Alzheimer's disease
@en
P2093
Haruhisa Inoue
Isao Asaka
Kazutoshi Takahashi
Kei Maruyama
Masashi Asai
Naoki Yahata
Nobuhisa Iwata
Shiho Kitaoka
Takaomi C Saido
Takashi Asada
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0025788
P407
P577
2011-01-01T00:00:00Z